News
ZURICH, Sept 14 (Reuters) - Swiss drugmaker Roche ROG.S on Monday said two-thirds of spinal muscular atrophy (SMA) patients who have begun taking its new medicine Evrysdi have previously got rival ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results